Bibhu Mohanty, MD
Interventional Cardiology · Tampa, FLNPI 1720246242
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 37.2% of the total. Among interventional cardiology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 534 payments — averaging $320.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$64K
- Boston Scientific$54K
- Medtronic$28K
- Abbott$11K
- Philips North America LLC$3K
- Edwards Lifesciences$3K
- plus $8K from 20 others
Across 14 payments — averaging $9608.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$95K
- W. L. Gore & Associates, Inc.$25K
- Gentuity, LLC$13K
- Medtronic$2K
What the payments were for
- Consulting fees$77,71345%
- Speaking & faculty fees$40,09023%
- Travel & lodging$25,73315%
- Food & beverage$27,63716%
- Entertainment$130%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 47 | $63,680 |
| Boston Scientific | 92 | $54,214 |
| Medtronic(2 entities) | 234 | $28,133 |
| Abbott | 75 | $11,305 |
| Philips North America LLC | 5 | $3,474 |
| Edwards Lifesciences | 17 | $2,554 |
| Penumbra, Inc. | 7 | $2,119 |
| Abiomed | 20 | $1,403 |
| Angiodynamics, Inc. | 5 | $1,391 |
| Artivion, Inc. | 3 | $769 |
| Opsens Inc. | 8 | $457 |
| Cardiovascular Systems Inc. | 6 | $209 |
| Procyrion, Inc. | 1 | $192 |
| Celonova Biosciences, Inc. | 1 | $176 |
| Atricure, Inc. | 1 | $160 |
| Baylis Medical Company Inc | 1 | $154 |
| Asahi Intecc USA, Inc. | 1 | $146 |
| Teleflex LLC | 1 | $142 |
| Braemar Manufacturing, LLC | 1 | $140 |
| Biosense Webster, Inc. | 2 | $126 |
| United Therapeutics Corporation | 1 | $117 |
| Irhythm Technologies, Inc. | 1 | $35 |
| Cardiva Medical, Inc. | 1 | $33 |
| Shockwave Medical, Inc | 1 | $24 |
| Boehringer Ingelheim | 1 | $20 |
| CSL Behring | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$60,954
- GORE CARDIOFORM ASD Occluder$50,529
- VersaCross Access Solution$19,124
- COREVALVE EVOLUT R$16,174
- GENERAL - THERAPIES$14,560
- CoreValve Evolut$6,963
- Watchman$4,848
- MitraClip System$4,548
- AVVIGO Guidance System$4,500
- Indigo$2,535
- (2858) General Consulting$2,208
- WATCHMAN Access System$1,488
- MitraClip$1,434
- AngioVac$1,376
- Mitra Clip system$1,161
- (5091) Amb Mon & Diag Und$1,043
- Impella$695
- On-X$614
- Edwards SAPIEN 3 Transcatheter Heart Valve$593
- SYNERGY$529
How this compares
$171,186 in reported general payments places this provider in the 95th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $79,386 |
| Repatha SureclickEvolocumab | 36 | $45,866 |
| XareltoRivaroxaban | 47 | $41,317 |
| EntrestoSacubitril/Valsartan | 23 | $35,429 |
| Praluent PenAlirocumab | 12 | $13,339 |
| Metoprolol Succinate | 130 | $2,371 |
| Ranolazine ErRanolazine | 19 | $2,061 |
| Atorvastatin Calcium | 102 | $1,054 |
| ClopidogrelClopidogrel Bisulfate | 77 | $1,012 |
| Carvedilol | 75 | $769 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 13 | $768 |
| Rosuvastatin Calcium | 81 | $521 |
| Amlodipine Besylate | 72 | $513 |
| Pravastatin Sodium | 14 | $498 |
| Valsartan | 22 | $494 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Tampa
- Jesal PopatTampa$206K
- Saleem SaiyadTampa$107K
- Arthur LeeGainesville$1.8M
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.